Literature DB >> 33718161

A Survival-Related Competitive Endogenous RNA Network of Prognostic lncRNAs, miRNAs, and mRNAs in Wilms Tumor.

HengChen Liu1, MingZhao Zhang1, ManYu Shi1, TingTing Zhang1, ZeNan Zhang1, QingBo Cui1, ShuLong Yang1, ZhaoZhu Li1.   

Abstract

Wilms tumor (WT) commonly occurs in infants and children. We evaluated clinical factors and the expression of multiple RNAs in WT samples in the TARGET database. Eight long non-coding RNAs (lncRNAs; AC079310.1, MYCNOS, LINC00271, AL445228.3, Z84485.1, AC091180.5, AP002518.2, and AC007879.3), two microRNAs (miRNAs; hsa-mir-152 andhsa-mir-181a), and nine messenger RNAs (mRNAs; TCTEX1D4, RNF133, VRK1, CCNE1, HEY1, C10orf71, SPRY1, SPAG11A, and MAGEB18) were screened from differentially expressed RNAs and used to construct predictive survival models. These models showed good prognostic ability and were highly correlated with tumor stage and histological classification. Additionally, survival-related ceRNA network was constructed using 35 RNAs (15 lncRNAs, eight miRNAs, and 12 mRNAs). KEGG pathway analysis suggested the "Wnt signaling pathway" and "Cellular senescence" as the main pathways. In conclusion, we established a multinomial predictive survival model and a survival-related ceRNA network, which provide new potential biomarkers that may improve the prognosis and treatment of WT patients.
Copyright © 2021 Liu, Zhang, Shi, Zhang, Zhang, Cui, Yang and Li.

Entities:  

Keywords:  Wilms tumor; competing endogenous RNA/ceRNA; lncRNA; mRNA; miRNA; target

Year:  2021        PMID: 33718161      PMCID: PMC7953909          DOI: 10.3389/fonc.2021.608433

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  43 in total

Review 1.  Non-coding RNAs as regulators in epigenetics (Review).

Authors:  Jian-Wei Wei; Kai Huang; Chao Yang; Chun-Sheng Kang
Journal:  Oncol Rep       Date:  2016-11-08       Impact factor: 3.906

2.  Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.

Authors:  K-R Zhu; Q-F Sun; Y-Q Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-07       Impact factor: 3.507

Review 3.  The bright side of dark matter: lncRNAs in cancer.

Authors:  Joseph R Evans; Felix Y Feng; Arul M Chinnaiyan
Journal:  J Clin Invest       Date:  2016-08-01       Impact factor: 14.808

4.  MicroRNA-613 attenuates the proliferation, migration and invasion of Wilms' tumor via targeting FRS2.

Authors:  H-F Wang; Y-Y Zhang; H-W Zhuang; M Xu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-08       Impact factor: 3.507

5.  miR-30d Induced Apoptosis by Targeting Sox4 to Inhibit the Proliferation, Invasion and Migration of Nephroblastoma.

Authors:  Shi Zong; Jia Zhao; Ling Liu
Journal:  Onco Targets Ther       Date:  2020-07-27       Impact factor: 4.147

6.  Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma.

Authors:  Qing-Ming Wang; Guang-Yu Lian; Yuan Song; Zhi-Da Peng; Sheng-Hua Xu; Yi Gong
Journal:  Cancer Gene Ther       Date:  2018-11-23       Impact factor: 5.854

7.  Comparative Interactomes of VRK1 and VRK3 with Their Distinct Roles in the Cell Cycle of Liver Cancer.

Authors:  Namgyu Lee; Dae-Kyum Kim; Seung Hyun Han; Hye Guk Ryu; Sung Jin Park; Kyong-Tai Kim; Kwan Yong Choi
Journal:  Mol Cells       Date:  2017-09-20       Impact factor: 5.034

8.  The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

Authors:  Rui Yang; Lei Xing; Xiaying Zheng; Yan Sun; Xiaosong Wang; Junxia Chen
Journal:  Mol Cancer       Date:  2019-01-08       Impact factor: 41.444

9.  Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression.

Authors:  Yi Bai; Junyu Long; Zhisong Liu; Jianzhen Lin; Hanchan Huang; Dongxu Wang; Xu Yang; Fei Miao; Yilei Mao; Xinting Sang; Haitao Zhao
Journal:  J Cell Physiol       Date:  2019-03-27       Impact factor: 6.384

10.  Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour.

Authors:  Fucai Tang; Zechao Lu; Jiamin Wang; Zhibiao Li; Weijia Wu; Haifeng Duan; Zhaohui He
Journal:  BMC Med Genomics       Date:  2019-12-16       Impact factor: 3.063

View more
  4 in total

1.  Development and validation of prognostic m6A-related lncRNA and mRNA model in thyroid cancer.

Authors:  Yu Zhu; Tian Yu; Ju Huang; Xitao Ma; Tao Shen; Annuo Li; Rensong Yue
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

2.  VRK1 Predicts Poor Prognosis and Promotes Bladder Cancer Growth and Metastasis In Vitro and In Vivo.

Authors:  Jiacheng Wu; Tao Li; Hao Ji; Zhi Chen; Baoqian Zhai
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.810

3.  The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms.

Authors:  Cecilie Abildgaard; Luisa Matos do Canto; Cláudia Aparecida Rainho; Fabio Albuquerque Marchi; Naiade Calanca; Marianne Waldstrøm; Karina Dahl Steffensen; Silvia Regina Rogatto
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

4.  A ceRNA Network Composed of Survival-Related lncRNAs, miRNAs, and mRNAs in Clear Cell Renal Carcinoma.

Authors:  Wenjun Lu; Hengchen Liu; Xin Zhang; Yujun Guo; Lu Liu; Tieyun Guo; Liqin Qu; Shulong Yang; Zhaozhu Li
Journal:  Comput Math Methods Med       Date:  2022-04-28       Impact factor: 2.238

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.